Home
Michael H. Davidson, CEO: NewAmsterdam Pharma NAMS Sell · Filed 02/26
Trade details
- Type
- Insider sale
- Amount
- $617,302.56
- Shares · price
- 17,924 sh · $34.44 a share
- Held after
- 174,144 sh
- Person
- Michael H. DavidsonCEO
- Trade date
- 26/02/26
- Filed
- 26/02/26
- Days to filing
- 0 days
Sold 9.3% of holdings
- Share of holding sold
- 9.3%
NewAmsterdam Pharma trades, last 26 weeks
What else happened in NewAmsterdam Pharma around then
Filed or reported within 30 days of the trade day · 01/27~03/28Michael H. Davidson's recent trades
- Michael H. Davidson
SellNewAmsterdam Pharma
SellNewAmsterdam Pharma
NAMS
$14.8M
443,707 sh
$14.8M
Filed 03/02
Traded 03/02
- Michael H. Davidson
Planned saleNewAmsterdam Pharma
Planned saleNewAmsterdam Pharma
NAMS
$15.7M
443,707 sh
$15.7M
Filed 03/02
Traded 03/02
- Michael H. Davidson
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$5.6M
165,408 sh
$5.6M
Filed 02/26
Traded 02/26
- Michael H. Davidson
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$2.2M
61,547 sh
$2.2M
Filed 02/26
Traded 02/24
- Michael H. Davidson
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 planNewAmsterdam Pharma
NAMS
$1.6M
46,517 sh
$1.6M
Filed 02/26
Traded 02/25